FABP3, FABP4, and heart rate variability among patients with chronic schizophrenia

Wei-Chin Hung1,2, Teng-Hung Yu1,2, Cheng-Ching Wu1,2,3

  • 1Division of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.

PubMed

Insights

Elevated fatty acid-binding protein (FABP)3 and FABP4 levels are associated with reduced heart rate variability (HRV) in patients with chronic schizophrenia, indicating potential cardiovascular disease risks.

Area of Science:

  • Cardiology
  • Psychiatry
  • Biochemistry

Background:

  • Schizophrenia patients have a high prevalence of cardiovascular disease (CVD) and related deaths.
  • Low heart rate variability (HRV) is linked to an increased risk of CVD.
  • Fatty acid-binding proteins (FABP)3 and FABP4 are increasingly recognized for their roles in CVD development and progression.

Purpose of the Study:

  • To investigate the association between circulating FABP3 and FABP4 levels and HRV in individuals with chronic schizophrenia.
  • To explore potential biomarkers for CVD risk in this patient population.

Main Methods:

  • 265 patients with chronic schizophrenia were included.
  • Plasma concentrations of FABP3 and FABP4 were measured using enzyme-linked immunosorbent assay.
  • Standard HRV was recorded, and analyses included tertiles of FABP3/FABP4 and linear regression.

Main Results:

  • FABP3 showed negative associations with high-frequency (HF) HRV.
  • FABP4 demonstrated negative associations with both HF and low-frequency (LF) HRV.
  • Significant inverse associations were found between FABP3/FABP4 levels and HRV parameters.

Conclusions:

  • Elevated FABP3 and FABP4 levels may be associated with increased CVD-related health issues in chronic schizophrenia.
  • FABP3 and FABP4 could serve as potential indicators for cardiovascular risk in schizophrenia patients.
Abstract

Related Concept Videos

Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
2.9K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
28
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.9K